Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-088516
Filing Date
2025-06-20
Accepted
2025-06-20 16:15:18
Documents
2
Period of Report
2025-06-17

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1606
2 EX-24.1 ck0001768446-ex24_1.htm EX-24.1 18845
  Complete submission text file 0000950170-25-088516.txt   22011
Mailing Address C/O MAGENTA THERAPEUTICS, INC. 50 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address
Driscoll Cindy (Reporting) CIK: 0001741269 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40708 | Film No.: 251061530

Mailing Address 20 WILLIAM STREET SUITE 145 WELLESLEY HILLS MA 02481
Business Address 20 WILLIAM STREET SUITE 145 WELLESLEY HILLS MA 02481 1-866-857-2596
Climb Bio, Inc. (Issuer) CIK: 0001768446 (see all company filings)

EIN.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)